Validus downgraded to Neutral from Conviction Buy at Goldman Goldman believes Validus' premiums will not pick-up near-term until the company tests mid-year renewals and that upside is limited until the company completes the Flagstone acquisition. Price target lowered to $40 from $43.
News For VR From The Last 14 Days
Check below for free stories on VR the last two weeks.
Subscribe for More Information